Grace Therapeutics, Inc. — Form D

Grace Therapeutics, Inc. of Princeton, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-25. The offering totals $838K, of which $373K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Jean-Marie (John) N CananDirectorLaval, A8
Roderick N CarterDirectorLaval, A8
Janelle D'AlviseDirectorLaval, A8
Donald N OldsDirectorLaval, A8
Janelle D'AlviseExecutive OfficerLaval, A8
Linda P O'KeefeExecutive OfficerLaval, A8
Donald OldsDirectorMcLean, VA
Robert J. DelAversanoExecutive OfficerPrinceton, NJ
Amresh KumarExecutive OfficerPrinceton, NJ
Prashant KohliDirectorPrinceton, NJ
Prashant KohliExecutive OfficerPrinceton, NJ
Carrie D'AndreaExecutive OfficerPrinceton, NJ
S. George KottayilDirectorPrinceton, NJ
Edward NeugeborenDirectorPrinceton, NJ
A. Brian DavisDirectorWinston-Salem, NC
Dr. R. Loch MacdonaldExecutive OfficerPrinceton, NJ
Vimal KavuruDirectorPrinceton, NJ
Brian FordExecutive OfficerCharlotte, NC
Michael DerbyDirectorLaval, A8
Ronald DenisDirectorLaval, A8
Marc LebelDirectorChelmsford, MA
MARTIN GODBOUTDirectorMONTREAL, A8
Tina SampalisExecutive OfficerLAVAL, A8
Michel ChartrandDirectorLAVAL, A8
Henri HarlandDirectorLAVAL, A8

Other filings by this issuer (3)

FiledFormOfferingSold
2025-02-25D$30.0M$15.0M
2023-10-10D$15.1M$7.5M
2011-09-02D$170K

More